A New Wound Patch That Stops Arterial Bleeding in a Few Minutes is Being Evaluated by the US Military.
--Commercial Release Expected Within One Year--
MADISON, Wis., Oct. 26 /PRNewswire/ -- In animal studies at the University of Wisconsin, the Hemarrest(TM) Patch, a wound care patch developed by Clarion Pharmaceuticals Inc., stopped arterial bleeding in less than five minutes. Approximately 2.5 million cases of coronary catheterization A coronary catheterization is a minimally invasive procedure to access the coronary circulation and blood filled chambers of the heart using a catheter. It is performed for both diagnostic and interventional (treatment) purposes. are undertaken in the US alone. According to according to
1. As stated or indicated by; on the authority of: according to historians.
2. In keeping with: according to instructions.
3. Clarion Pharmaceuticals' founder and President, Dr. Thaddeus Pruss, there are currently no comparable treatments for stopping the arterial hemorrhaging that occurs as part of this procedure. In a comparative test against competing products, the Hemarrest(TM) Patch demonstrated superior efficacy and is projected to have significant cost advantages.
The US military is currently evaluating Hemarrest(TM) Patch. Clarion expects that the Hemarrest(TM) Patch will be the military's product of choice because of its superior performance in treating various forms of trauma. Because all of the components of the Hemarrest(TM) Patch are FDA approved, Clarion estimates that the product will be approved by the FDA within 12 months.
Clarion Pharmceuticals Inc. holds the patents on this product and several other key compounds that will provide for significant enhancements to treating medical conditions See carpal tunnel syndrome, computer vision syndrome, dry eyes and deep vein thrombosis. in wound care and respiratory therapy respiratory therapy
Medical profession concerned with assisting the respiratory function of individuals who have severe lung disorders. Practices include suctioning to clear secretions from the airway, use of aerosol mists (sometimes medicated) or gases to ease breathing, . Plans are to establish its wound care business in Cleveland, Ohio, while corporate headquarters will remain in Madison Wisconsin.